# Steve Collins

> Steve Collins is a Series C investor at Novo Holdings backing Health Care. See 1 investments, check sizes, portfolio and contact details. Updated Oct 2026.

- Type: Angel Investor
- Fund: [Novo Holdings](https://shizune.co/investors/profile/novo-a-s)
- Location: Charlotte, United States
- Total investments: 1
- Last investment: Apr 2014
- Lead investor: 100%
- Last updated: Oct 2026
- LinkedIn: https://www.linkedin.com/in/steve-collins-2966577

Steve Collins is a Series C investor at Novo Holdings in Charlotte focused on Health Care and Biotechnology. Steve Collins - National Account Executive @ Novo Holdings

## Contacts

5 contacts available for Steve Collins: work email, personal email, work phone, personal phone and socials. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-email/steve-collins-nc?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 1 | 100% |
| Biotechnology | 1 | 100% |
| Pharmaceutical | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Spinifex Pharmaceuticals | Spinifex is backed by a syndicate of experienced life science investors including Novo Ventures, Canaan Partners, GBS Venture Partners, Brandon Capital Partners, Uniseed and UniQuest. Founded in 2005, Spinifex raised an initial AU$3.25 million in Series A fundraising and a total of AU$23.08 in Series B funding support the further development ofEMA401. Spinifex raised a US$45 million in a Series C round led by Novo Ventures and including additional new investor Canaan Partners in 2014.Spinifex has a strong portfolio of intellectual property around its lead compound EMA01, follow on candidates and the use of AT2 receptor antagonists to treat both neuropathic & inflammatory pain and restore nerve conduction velocity deficits, including granted US, European, Japanese, Chinese, Australian and New Zealand patents. | $45M | Series C | Apr 10, 2014 | http://www.spinifexpharma.com.au |

1 of 1 investments shown.

## Co-investors
- [Uniseed](https://shizune.co/investors/profile/uniseed-vc) — VC Fund, 2 deals together
- [Brandon Capital](https://shizune.co/investors/profile/brandon-capital-partners) — VC Fund, 1 deal together
- [Canaan Partners](https://shizune.co/investors/profile/canaan-partners) — VC Fund, 1 deal together
- [GBS Ventures](https://shizune.co/investors/profile/gbs-ventures) — VC Fund, 1 deal together
- [UniQuest](https://shizune.co/investors/profile/uniquest-5ba9) — VC Fund, 1 deal together
- [Uniseed Ventures](https://shizune.co/investors/profile/uniseed-pty) — VC Fund, 1 deal together

## About Novo Holdings

VC Fund · Hellerup, Denmark

Novo Holdings is a holding and investment firm that manages the assets of the Novo Nordisk Foundation. It is a life science investor with a diverse portfolio that includes equities, bonds, real estate, infrastructure, and private investments.

5 contacts available at Novo Holdings.

| Name | Title | Profile |
| --- | --- | --- |
| Emmanuelle Coutanceau | Partner Novo Seeds | https://shizune.co/investors/profile/emmanuelle-coutanceau |
| Steve Collins | National Account Executive | https://shizune.co/investors/profile/steve-collins-nc |
| Thomas Dyrberg | Partner | https://shizune.co/investors/profile/thomas-dyrberg |
| Thomas Grotkjær | Investor & Principal | https://shizune.co/investors/profile/thomas-grotkj%C3%A6r |
| Abhijeet Lele | Senior Partner and Head of US Principal Investments | https://shizune.co/investors/profile/abhijeet-lele |

## Similar investors

### Similar stage
- [New Enterprise Associates](https://shizune.co/investors/profile/new-enterprise-associates) — VC Fund
- [Bessemer Venture Partners](https://shizune.co/investors/profile/bessemer-venture-partners) — VC Fund
- [Qiming Venture Partners](https://shizune.co/investors/profile/qiming-venture-partners) — VC Fund

## FAQ

### What does Steve Collins invest in?

Steve Collins invests primarily in Health Care, Biotechnology and Pharmaceutical startups, most often at Series C stage. Most of the 1 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Steve Collins?

Public channels for Steve Collins include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### When did Steve Collins last invest?

The most recent investment recorded for Steve Collins closed in Apr 2014. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co